Perifollicular xanthoma occurring after treatment with osimertinib

Eur J Dermatol. 2023 Oct 1;33(5):562-564. doi: 10.1684/ejd.2023.4547.

Authors

Masahiro Yamada¹, Hiraku Kokubu², Noriki Fujimoto²

Affiliations

¹ Hikone Municipal Hospital, Hikone, Hassaka Shiga 522-8539, Japan, Department of Dermatology, Shiga University of Medical Science, Setatsukinowa, Otsu, Shiga 520-2192, Japan.
² Department of Dermatology, Shiga University of Medical Science, Setatsukinowa, Otsu, Shiga 520-2192, Japan.

PMID: 38297939
DOI: 10.1684/ejd.2023.4547

No abstract available

MeSH terms

Acrylamides / adverse effects
Aniline Compounds / adverse effects
Humans
Indoles*
Lung Neoplasms*
Mutation
Protein Kinase Inhibitors
Pyrimidines*
Xanthomatosis* / chemically induced

Substances

osimertinib
Acrylamides
Aniline Compounds
Protein Kinase Inhibitors
Indoles
Pyrimidines